药物对比
Insulin Glulisine Human vs Donislecel
Insulin glulisine（Apidra）与 donislecel（Lantidra）：速效胰岛素类似物与1型糖尿病胰岛细胞疗法的比较。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered for type 1 diabetes patients with recurrent severe hypoglycemia despite intensive regimens using rapid-acting insulins.
结论
Insulin glulisine suits broad daily glycemic control while donislecel targets a narrow subset of type 1 patients with hypoglycemia unawareness.
全部药物对比